Search results
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea - WTOP News
WTOP Washington· 7 hours agoEli Lilly and Co., the drug’s maker who paid for the research, has asked the Food and Drug < ...
Abortion Pill Access Is Still Under Threat After SCOTUS Ruling, Legal Experts Warn
Scientific American· 4 days ago“Anybody that values reproductive freedom and the scientific integrity of the [U.S. Food and Drug
Weight-loss drug effective in treating apnea, study finds
UPI· 7 hours agoResearchers at University of California-San Diego School of Medicine and international collaborators...
Opinion: Access to new Alzheimer’s treatments bogged down by Medicare policy
Bangor Daily News· 1 day agoJoe Grogan is a senior fellow at the University of Southern California’s Schaeffer Center for Health...
Alzheimer's drug's potentially fatal side effect, ARIA, obscured by 'soothing acronym,' doctors say
LA Times via Yahoo News· 5 days agoGenevieve Lane, who took Leqembi, died of a mysterious side effect called ARIA. Her death, and those...
FDA Warns of Contaminated Oysters and Clams | Newswise
Newswise· 2 days agoThe Food and Drug Administration says shellfish from a number of states could be contaminated with ...
Gateway - Quartz
Quartz· 3 days agoThe US Food and Drug Administration (FDA) announced yesterday that it updated its rules for prescribing mifepristone ...
How Big Tobacco enlists Black activists to fight menthol, vaping bans
Washington Post· 17 hours agoFowlkes’s promotion of looser e-cigarette regulations, which came as he developed a relationship...
CCHR Applauds FDA Panel Rejecting MDMA Psychedelic for Mental Health Treatment
Digital Journal· 5 days agoA panel of experts from the Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory ...
Researchers Still Fighting For MDMA Therapy After FDA Advisors Vote Against It - Slashdot
Slashdot· 24 hours agoAn anonymous reader quotes a report from the BBC: A vote against using MDMA as part of therapy for PTSD has provoked a powerful backlash among researchers who study psychedelic ...